Tissue repositories are any facilities that collect or store tissue for research purposes. According to the HHS, tissue repositories are not covered entities under HIPAA unless they engage in specific healthcare activities that qualify them as such. For instance, if a tissue repository conducts testing on specimens for the benefit of transplant recipients based on orders from another healthcare provider, it would be classified as a covered entity under HIPAA, provided it also performs electronic transactions that are subject to standards set by the Department of Health and Human Services (HHS).
HIPAA defines covered entities as organizations that fall into one of three categories:
Most tissue repositories do not perform activities that fit into these categories and are not covered entities.
Related: FAQs: HIPAA covered entities’
While tissue repositories generally fall outside the HIPAA definition of a covered entity, certain activities can bring them under HIPAA’s scope.
If a tissue repository conducts specimen testing, such as compatibility testing for transplant recipients, it may qualify as a healthcare provider. For example, a tissue bank that tests donor organs for compatibility and bills a transplant center through an electronic claims system could be classified as a covered entity.
HIPAA applies to organizations that perform certain standardized electronic transactions. Tissue repositories involved in activities like electronic claims submission, payment processing, or eligibility verification for healthcare services may qualify as covered entities under this rule.
Even if a tissue repository is not a covered entity, it may still need to comply with HIPAA as a business associate. A business associate is any organization that handles protected health information (PHI) on behalf of a covered entity. For instance: a tissue repository partnering with a hospital to store and manage samples tied to PHI would be considered a business associate. In such cases, the repository must sign a business associate agreement (BAA) with the covered entity and implement safeguards to protect the PHI it handles.
Many tissue repositories handle de-identified samples or data, stripped of identifiers like names, birthdates, and other elements that could link the sample to an individual. HIPAA does not apply to repositories managing such data, as de-identified information falls outside the scope of the Privacy Rule.
Repositories that focus on research often anonymize their samples to avoid the HIPAA requirements. However, they must still follow de-identification standards outlined by HIPAA to ensure compliance and reduce risk.
Read more: How to de-identify protected health information for privacy
No, research-only tissue repositories are generally not subject to HIPAA because they do not perform healthcare functions or engage in electronic transactions regulated under HIPAA. However, other regulations like the Common Rule or state laws may still apply.
Yes, but only if the covered entity obtains patient authorization or an institutional review board (IRB) waives the authorization requirement. Otherwise, the repository must use de-identified data.
Handling PHI without a valid BAA could result in non-compliance, exposing both the repository and the covered entity to potential HIPAA violations and penalties. Repositories should confirm BAAs are in place before working with PHI.